Clinical trials
Enrolling by invitation Phase 2/3 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| First Affiliated Hospital of Zhejiang University | 2 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Guangdong Second Provincial General Hospital | 1 |
| Han Ying | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| Shandong New Time Pharmaceutical Co., LTD | 1 |
| The First Affiliated Hospital of Soochow University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 3 |
| Glomerulonephritis, IGA | 1 |
| Leukemia, Promyelocytic, Acute | 1 |
| Liver Cirrhosis, Biliary | 1 |
| Neoplasm, Residual | 1 |
| Triple Negative Breast Neoplasms | 1 |
| Uterine Cervical Neoplasms | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.